Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Inventory (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Inventory for 12 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory rose 74.49% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, up 74.49%, and an annual FY2024 reading of $904000.0, up 8.0% over the prior year.
  • Inventory was $1.5 million for Q3 2025 at Arcadia Biosciences, down from $1.5 million in the prior quarter.
  • Across five years, Inventory topped out at $5.4 million in Q3 2021 and bottomed at $835000.0 in Q3 2024.
  • Average Inventory over 5 years is $2.5 million, with a median of $2.6 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 200.75% in 2021, then plummeted 69.09% in 2024.
  • Year by year, Inventory stood at $4.4 million in 2021, then crashed by 47.64% to $2.3 million in 2022, then plummeted by 63.94% to $837000.0 in 2023, then rose by 8.0% to $904000.0 in 2024, then surged by 61.17% to $1.5 million in 2025.
  • Business Quant data shows Inventory for RKDA at $1.5 million in Q3 2025, $1.5 million in Q2 2025, and $1.3 million in Q1 2025.